In addition, studies have displayed that in osteosarcoma cells, RRP12 can enhance the resistance of tumor cells to chemotherapeutic drugs; after the expression of RRP12 was disturbed, the expression of p53 was significantly upregulated. Here, RRP12 is linked to osteosarcoma.